PKM and prostate carcinoma: A prior study reported that PKM2 transferred via endosomes increases the expression of CXCL12 in recipient prostate cancer cells in bone marrow [51], which could initiate a feed-forward pathway, allowing for disseminated tumor cells to survive and proliferate.